Bortezomib in the treatment of multiple myeloma

Bortezomib in the treatment of multiple myeloma

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...

全面介紹

書目詳細資料
發表在:Springer eBooks.
企業作者: SpringerLink (Online service)
其他作者: Ghobrial, Irene M., Richardson, Paul G., Anderson, Kenneth C.
格式: Electronic Resource
語言:English
出版: Basel Springer Basel c2011.
主題:
Multiple myeloma > Treatment.
Multiple myeloma > Chemotherapy.
Antineoplastic agents.
Boronic Acids > Therapeutic use.
Multiple myeloma > Drug therapy.
Antineoplastic agents > Therapeutic use.
Protease inhibitors > Therapeutic use.
Proteasome endopeptidase complex > Antagonists & inhibitors.
Pyrazines > Therapeutic use.
Electronic books.
在線閱讀:Available for University of the Philippines Diliman via SpringerLink. Click here to access